Volver a Agenda
Session Chair(s)
Joan Meyer
Covance, United States
Learning Objective : Discuss the concept of a responder in a clinical trial; Describe ways to use data to increase the recruitment of responders into clinical studies.
Speaker(s)
Industry Perspective
Joan Meyer
Covance, United States
FDA Perspective on Use of Biomarkers to Identify Treatment Responders
Christopher Leptak, MD, PHD
Greenleaf Health, Inc., United States
Executive Vice President, Drug and Biological Products
Pharmaceutical Perspective
Cecile Holweg
Genentech, A Member of the Roche Group, United States
¿Tiene una cuenta?